The Big Idea
How psyched would you be if you went to your healthcare provider and they said the following:
“I can make a health optimization recommendation for you, informed not only by the latest clinical trials, but also by local and regional data about like...
Read More
A Normal Breather
As the market pushed sharply higher following its early-October low (10% or so in the S&P 500, 12%-plus in the Nasdaq), rising seven out of eight weeks, the worries of the world (trade wars, slowing economic growth, even impeachment) were slowly As...
Read More
Mostly Sunny, Chance of Passing Showers
Seven weeks ago, the market was getting hit and growth stocks were looking awful. We were definitely cautious, but on this page we also wrote the following:
“We don’t want to sound too negative. It’s still a bull market, we...
Read More
Market: Great. Growth Stocks: Just OK
Ever since the indexes turned on a dime at the beginning of this year, we’ve been leaning bullish on the general market, and in recent months, even as things have chopped around and there’s been an avalanche of we’ve...
Read More
THE BIG IDEA
In its 2017 infrastructure report card the American Society of Civil Engineers (ASCE) gave America’s infrastructure a grade of “D+”.
America received the same grade in 2013. That was an improvement over 2009 (and 2005) when we received a “D”.
Suffice to say, room...
Read More
Less Remains More
Way back in the day the late, great Joe Granville once said that “the market is the train, and I’m the caboose,” which is a good summation of our general philosophy over the years. At heart, we’re trend followers, getting heavily when...
Read More
Patience Precedes Profits
We regularly write about practicing patience with your winning stocks, and that will always be a key factor in making big money—unless you’re a savant, you’ll find that many of your trades will offset over time (small losses, break-evens, small wins, with...
Read More
THE BIG IDEA
There are over 100 million people around the world suffering from obstructive sleep apnea (OSA), a condition in which a partially blocked airway prevents airflow to the lungs when a person is asleep. The typical length of a breathing pause is seconds...
Read More
Aggravation-to-Profit Ratio: High
Everybody loves a persistent uptrend in growth stocks, especially us; we know how to find the winners and ride them for the majority of their advance. That’s where the real money is! And while we don’t ever root for a big we...
Read More
The unemployment-stock market correlation is a picture-perfect inverse on a chart. Now that unemployment can't sink much lower, where do stocks go?
Read More
Mixed Messages
The market is never easy to read, but the past week has been about as confusing as you’ll ever see. On one hand, leading stocks have been taken to the woodshed. Software and cybersecurity, which were two of the best performers this have...
Read More
THE BIG IDEA
I have vague memories of the Electrolux vacuum salesman coming to our house to sell his wares. Over the last 40 or so years, the basic idea of enticing people to take advantage of a “deal” hasn’t changed much. But the and...
Read More
Lots of Drama, But the Evidence is Unchanged
August is winding to a close, and we say good riddance—this month has packed in as many dramatic market-moving headlines as any we can remember due to developments in the U.S.-China trade battle, speeches from the Reserve...
Read More
Play Some Defense
Usually, when the market is doing well, stocks aren’t affected much by the news of the day. That’s not to say individual stocks don’t get pushed around, but for the market as a whole, worrisome headline news usually goes the way water...
Read More
THE BIG IDEA
Back in the late 1800s if you called a company for information you were routed through a telephone exchange and were able to speak with a person that could help.
The last switchboard operator for a hand-crank phone, Susan Glines, walked away her...
Read More
Passing T-Storms—or Something More?
On this page of the last issue, we wrote “we think the near-term is a toss-up, at least when it comes to individual growth stocks— earnings season is always tricky, and let’s face it, many leaders have had great runs the...
Read More
Mostly Sunny—with Possible T-Storms Along the Way
Ever since January 9, when the 2-to-1 Blastoff Indicator gave a rare buy signal just two weeks after the market’s major bottom, our greatest conviction has been that the overall market had likely entered a new bull that...
Read More
The Odds Still Favor Higher Prices Ahead
It was a solid first half of 2019 for most major indexes and growth stocks. Despite a few knocks upside the head last week, our Model Portfolio finished June up nearly 22% on the year. In fact, the...
Read More
THE BIG IDEA
A few years back the Institute of Medicine (IOM) published a report with an astounding conclusion:
Most people will experience at least one diagnostic error in their lifetime, sometimes with devastating consequences.
That’s not cool.
Diagnostic accuracy of some conditions is staggeringly bad. For the...
Read More
Still Going According to Script
Back on January 31, we wrote that the market was basically following a perfect Hollywood-type script for a major market bottom—you had a three-month bear phase that produced huge oversold readings and massive pessimism near the low, followed by turn...
Read More